Protocol Intelligence

Protocol Intelligence is a private health technology and precision oncology company developing software to guide personalized treatment decisions in multiple myeloma. Its core product is an AI- and mathematical model-driven clinical decision support system designed to predict the evolution of drug-resistant myeloma subpopulations and optimize drug selection, timing, and sequencing for individual patients. The company combines cloud software, curated clinical and molecular data, and companion diagnostic coordination, and has indicated plans to pursue FDA clearance as a software-as-a-medical-device product. Protocol Intelligence has operated out of San Diego and has been associated with JLABS, with retrospective model-training work involving data from major myeloma research centers. The business appears to be focused on oncology data science and clinical workflow support rather than on developing proprietary therapeutic drugs.